UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

|X|   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
      EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2007

|_|   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
      EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM         TO

                        COMMISSION FILE NUMBER: 000-25839

                            SYSVIEW TECHNOLOGY, INC.
             (Exact name of registrant as specified in its charter)

           DELAWARE                                            59-3134518
(State or other jurisdiction of                             (I.R.S.Employer
incorporation or organization)                           Identification Number)

                              1772 TECHNOLOGY DRIVE
                           SAN JOSE, CALIFORNIA 95110
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, ZIP CODE)

                              408-436-9888 EXT. 207
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the preceding 12 months (or for such
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes |X| No |_|

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Act). Yes |_| No |X|

The number of shares of Common Stock outstanding as of May 15, 2007 was
21,842,092.

-------------------------------------------

Transitional Small Business Disclosure Format (check one): Yes |_| No |X|


                   SPECIAL NOTE ON FORWARD LOOKING STATEMENTS

This Quarterly Report on Form 10-QSB, including "Management's Discussion and
Analysis of Financial Condition and Results of Operations" in Item 2 of Part I
of this report include forward-looking statements. These statements involve
known and unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance, or
achievements expressed or implied by forward-looking statements.

In some cases, you can identify forward-looking statements by terminology such
as "may," "should," "expects," "plans," "anticipates," "believes," "estimates,"
"predicts," "potential," "proposed," "intended," or "continue" or the negative
of these terms or other comparable terminology. You should read statements that
contain these words carefully, because they discuss our expectations about our
future operating results or our future financial condition or state other
"forward-looking" information. There may be events in the future that we are not
able to accurately predict or control. Before you invest in our securities, you
should be aware that the occurrence of any of the events described in this
Quarterly Report could substantially harm our business, results of operations
and financial condition, and that upon the occurrence of any of these events,
the trading price of our securities could decline and you could lose all or part
of your investment. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee future results,
growth rates, levels of activity, performance or achievements. We are under no
duty to update any of the forward-looking statements after the date of this
Quarterly Report to conform these statements to actual results.


                                       2


PART I. FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

                            SYSVIEW TECHNOLOGY, INC.
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (IN THOUSANDS)



                                                                                 MARCH 31,      DECEMBER 31,
                                                                                    2007            2006
                                                                                ------------    ------------
                                                                                          
ASSETS                                                                           (Unaudited)       (Audited)
Current assets:
  Cash and cash equivalents                                                     $        864    $      1,333
  Trade receivables                                                                    2,502           1,813
  Inventories                                                                          1,310           1,642
  Prepaid expenses and other current assets                                              151              73
                                                                                ------------    ------------
     TOTAL CURRENT ASSETS                                                              4,827           4,861

Fixed assets, net                                                                        131             108
Long-term investment                                                                     160             160
                                                                                ------------    ------------
          TOTAL ASSETS                                                          $      5,118    $      5,129
                                                                                ============    ============

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Bank line of credit                                                           $      1,513    $      1,013
  Trade payables to related parties                                                      172             952
  Trade payables                                                                         286             198
  Other payables and accruals                                                            309             506
  Accrued dividends on Series A 5% cumulative convertible preferred stock                173             152
                                                                                ------------    ------------
     TOTAL CURRENT LIABILITIES                                                         2,453           2,821

Other liabilities:
  Liability under derivative contracts                                                   597             229
                                                                                ------------    ------------

          TOTAL LIABILITIES                                                            3,050           3,050

Commitments and contingencies (note 9)

Convertible preferred stock, $.001 par value, 2,000 authorized:
  Series A 5% cumulative convertible preferred stock, 16 shares issued and
     outstanding at March 31, 2007 and December 31, 2006; liquidation value
     of $1,565 at March 31, 2007 and December 31, 2006                                 1,082             957
  Series B convertible preferred stock, 11.5 shares issued and outstanding at
     March 31, 2007 and December 31, 2006; liquidation value of
     $1,150 at March 31, 2007 and December 31, 2006                                      247             152

Stockholders' equity:
  Common stock $.001par value, 50,000 authorized, 22,042 shares issued
     and 21,542 outstanding at March 31, 2007 and 24,642 shares issued
     and 24,142 outstanding at December 31, 2006 (500 shares held in escrow)              22              24
  Additional paid-in capital                                                          30,471          29,651
  Accumulated deficit                                                                (29,754)        (28,705)
                                                                                ------------    ------------
     TOTAL STOCKHOLDERS' EQUITY                                                          739             970
                                                                                ------------    ------------
          TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                            $      5,118    $      5,129
                                                                                ============    ============


    The accompanying notes are an integral part of these unaudited condensed
                       consolidated financial statements.


                                       3


                            SYSVIEW TECHNOLOGY, INC.
           CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
                    (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)



                                                                      THREE MONTHS ENDED
                                                                           MARCH 31,
                                                                 ----------------------------
                                                                     2007            2006
                                                                 ------------    ------------
                                                                           
NET SALES                                                        $      4,127    $      2,438

COST OF SALES                                                           2,484           1,616
                                                                 ------------    ------------

GROSS PROFIT                                                            1,643             822

Operating expenses:
  Selling and marketing                                                   400             293
  General and administrative                                              915             608
  Research and development                                                777             396
                                                                 ------------    ------------
TOTAL OPERATING EXPENSES                                                2,092           1,297
                                                                 ------------    ------------

OPERATING LOSS                                                           (449)           (475)
                                                                 ------------    ------------

OTHER INCOME (EXPENSE)
  Change in fair value of derivative instruments                         (368)            208
  Other                                                                     9              (5)
                                                                 ------------    ------------
TOTAL OTHER INCOME (EXPENSE)                                             (359)            203

                                                                 ------------    ------------
Net loss before income taxes                                             (808)           (272)
Provision for income taxes                                                 --              --
                                                                 ------------    ------------

Net loss                                                                 (808)           (272)
Dividend on Series A and accretion of Series A and Series B
   preferred stock redemption value                                      (241)           (148)
                                                                 ------------    ------------
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS                        $     (1,049)   $       (420)
                                                                 ============    ============

NET LOSS PER COMMON SHARE - BASIC AND DILUTED                    $      (0.04)   $      (0.02)
                                                                 ============    ============

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED         23,850          24,092
                                                                 ============    ============


    The accompanying notes are an integral part of these unaudited condensed
                       consolidated financial statements.


                                       4


                            SYSVIEW TECHNOLOGY, INC.
           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
                                 (IN THOUSANDS)



                                                                             THREE MONTHS ENDED
                                                                                  MARCH 31,
                                                                        ----------------------------
                                                                            2007            2006
                                                                        ------------    ------------
                                                                                  
OPERATING ACTIVITIES
Net loss available to common stockholders                               $     (1,049)   $       (420)
Adjustments to reconcile net loss to net cash used by
      operating activities:
  Depreciation expense                                                             9              11
  Stock-based compensation cost - options                                        814             295
  Fair value of warrants issued for services rendered                              4              --
  Change in fair value of derivative instruments                                 368            (208)
  Accretion of Series A and Series B preferred stock redemption value            220             128
  Changes in operating assets and liabilities:
     Trade receivables                                                          (689)           (430)
     Inventories                                                                 332             134
     Prepaid expenses and other current assets                                   (78)            (83)
     Accrued dividends on Series A 5% cumulative convertible stock                21              20
     Trade payables to related parties                                          (780)            449
     Trade payables and other current liabilities                               (109)           (278)
                                                                        ------------    ------------
CASH USED BY OPERATING ACTIVITIES                                               (937)           (382)
                                                                        ------------    ------------

INVESTING ACTIVITIES
  Capital expenditures                                                           (32)             (4)
                                                                        ------------    ------------
CASH USED BY INVESTING ACTIVITIES                                                (32)             (4)
                                                                        ------------    ------------

FINANCING ACTIVITIES
  Advances on bank line of credit                                                500              --
                                                                        ------------    ------------
CASH PROVIDED BY FINANCING ACTIVITIES                                            500              --
                                                                        ------------    ------------

NET DECREASE IN CASH AND CASH EQUIVALENTS                                       (469)           (386)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                               1,333           1,426
                                                                        ------------    ------------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                              $        864    $      1,040
                                                                        ============    ============

  NON-CASH INVESTING AND FINANCING ACTIVITIES:
    Common stock acquired from related party                            $          2    $         --
                                                                        ============    ============


    The accompanying notes are an integral part of these unaudited condensed
                       consolidated financial statements.


                                       5


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

NOTE 1 - BACKGROUND AND BASIS OF PRESENTATION

ORGANIZATION

Sysview Technology. Inc. ("Sysview" or "Company") develops, designs and delivers
various imaging technology solutions to all types and sizes of enterprises
including governmental agencies, large corporations, small corporations, small
office-home offices ("SOHO"), professional practices as well as consumers
(referred to herein collectively as "Enterprises"). Sysview is a market-leader
in providing USB-powered scanning solutions to a wide variety of industries and
market applications. The Company's patented and proprietary page-imaging devices
facilitate the way information is stored, shared and managed in both business
and personal use. In addition, Sysview is involved in the research and
development of certain technologies related to the field of high definition
("HD") display.

Syscan, Inc., the Company's wholly-owned subsidiary, was incorporated in
California in 1995 to develop and manufacture a new generation of contact image
sensors ("CIS") that are complementary metal-oxide-silicon ("CMOS") imaging
sensor devices. During the late 1990s, the Company established many technical
milestones and was granted numerous patents for its linear imaging technology.
The Company's patented CIS and mobile imaging scanner technology provides high
quality images at extremely low power consumption levels allowing delivery of
compact scanners in a form ideally suited for laptop or desktop computer users
who need a small light weight device to scan or fax documents.

The Company's business model was developed around intellectual property ("IP")
driven products sold primarily to original equipment manufacturers ("OEM"),
private label brands and value added resellers ("VAR") and can be found in a
variety of applications, including but not limited, to the following:

      o     Document and information management;
      o     Identification card scanners;
      o     Passport security scanners;
      o     Bank note and check verification;
      o     Business card readers;
      o     Barcode scanning; and
      o     Optical mark readers used in lottery terminals.

BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of
Sysview have been prepared in accordance with accounting principles generally
accepted in the United States for interim financial information and the
instructions to Form 10-QSB and Article 10 of Regulation S-X. Accordingly, they
do not include all information and disclosures necessary for a presentation of
the Company's financial position, results of operations, and cash flows in
conformity with accounting principles generally accepted in the United States
("GAAP").

In the opinion of management, all adjustments (which include only normal
recurring adjustments) necessary to present fairly the financial position,
results of operations and cash flows for all periods presented have been made.
Preparing financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenue and
expenses. Actual results may differ from these estimates. The results of
operations for the period ended March 31, 2007 are not necessarily indicative of
the operating results that may be expected for the entire year ending December
31, 2007. The interim financial statements should be read in conjunction with
the financial statements in the Company's Annual Report on Form 10-KSB for the
year ended December 31, 2006, filed with the Securities and Exchange Commission
("SEC") on April 3, 2007.

The consolidated financial statements include the accounts of Sysview and its
subsidiaries. All significant intercompany transactions and balances have been
eliminated.


                                       6


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

Certain accounts have been reclassified to conform to the current period
presentation. Such reclassifications did not affect total net sales, operating
loss or net loss available to common stockholders.

NOTE 2 - RECENT ACCOUNTING PRONOUNCEMENTS

In February 2006, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standard ("SFAS") 155, ACCOUNTING FOR CERTAIN
HYBRID FINANCIAL INSTRUMENTS - AN AMENDMENT OF FASB STATEMENTS 133 AND 140,
("SFAS 155"). SFAS 155 permits interests in hybrid financial instruments that
contain an embedded derivative that would otherwise require bifurcation, to be
accounted for as a single financial instrument at fair value, with changes in
fair value recognized in earnings. This election is permitted on an
instrument-by-instrument basis for all hybrid financial instruments held,
obtained, or issued as of the adoption date. Sysview adopted SFAS 155 on January
1, 2007 and will apply the standard to any new hybrid financial instruments
issued subsequent to January 1, 2007. However, as allowed by paragraph 4(c) of
SFAS 155, Sysview did not elect to apply SFAS 155 to previously existing hybrid
financial instruments including the Company's Series A 5% cumulative convertible
preferred stock ("Series A Stock") and Series B Convertible Preferred Stock
("Series B Stock"). As such, the adoption of SFAS 155 had no impact to the
Company's consolidated financial position, results of operations or cash flows.

In June 2006, the FASB issued Interpretation 48, ACCOUNTING FOR UNCERTAINTY IN
INCOME TAXES -- AN INTERPRETATION OF FASB STATEMENT NO. 109 ("FIN 48"), which
clarifies the accounting for uncertainty in tax positions. This Interpretation
requires that the Company recognize in its financial statements the impact of a
tax position if that position will more likely than not be sustained on audit,
based on the technical merits of the position. Sysview adopted FIN 48 on January
1, 2007. The adoption had no impact to the Company's consolidated financial
position, results of operations or cash flows.

In September 2006, the FASB issued SFAS 157, FAIR VALUE MEASUREMENTS ("SFAS
157"), which provides guidance about how to measure assets and liabilities that
use fair value. SFAS 157 will apply whenever another US Generally Accepted
Accounting Principle ("GAAP) standard requires (or permits) assets or
liabilities to be measured at fair value but does not expand the use of fair
value to any new circumstances. This standard also will require additional
disclosures in both annual and quarterly reports. SFAS 157 will be effective for
financial statements issued for fiscal years beginning after November 15, 2007,
and will be adopted by the Company January 1, 2008. The Company is currently
evaluating the potential impact this standard may have on its consolidated
financial position, cash flows and results of operations, but does not believe
the impact of the adoption will be material.

In February 2007, the FASB issued SFAS 159, THE FAIR VALUE OPTION FOR FINANCIAL
ASSETS AND FINANCIAL LIABILITIES-INCLUDING AN AMENDMENT OF FASB STATEMENT NO.
115 ("SFAS 159"). SFAS 159 permits entities to choose to measure many financial
instruments and certain other items at fair value that are not currently
required to be measured at fair value, with unrealized gains and losses related
to these financial instruments reported in earnings at each subsequent reporting
date. SFAS 159 will be effective for financial statements issued for fiscal
years beginning after November 15, 2007, and will be adopted by the Company
January 1, 2008. The Company does not expect the adoption of SFAS 159 to result
in a significant impact on its consolidated financial position, cash flows and
results of operations.

Other recent accounting pronouncements issued by the FASB (including its
Emerging Issues Task Force ("EITF")), the American Institute of Certified Public
Accountants ("AICPA"), and the SEC did not or are not believed by management to
have a material impact on the Company's present or future financial statements.

NOTE 3 - RELATED-PARTY TRANSACTIONS

RELATED-PARTY PURCHASES

The Company purchases the majority of its finished scanner imaging products from
Syscan Lab Limited ("SLL"), a wholly-owned subsidiary of Syscan Technology
Holdings Limited ("STH"), the parent company of Sysview's majority stockholder.
The Company's Chairman and CEO, Darwin Hu, was formerly the CEO of STH. He
resigned from STH effective December 2004.


                                       7


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

Purchases from SLL totaled $2,178,000 and $1,409,000 for the three months ended
March 31, 2007 and 2006, respectively. All purchases from SLL were carried out
in the normal course of business. As a result of these purchases, the Company
was liable to SLL for $172,000 and $952,000 at March 31, 2007 and December 31,
2006, respectively.

COMMON STOCK ACQUIRED FROM RELATED PARTY

On March 21, 2007, the Company entered into an agreement with STH whereby the
Company agreed to forego any further collections efforts related to loans that
were previously made by the Company to STH, which were never repaid by STH,
including legal action, in exchange for the cancellation of 2,600,000 shares of
the Company's common stock beneficially owned by STH. In addition, both parties
mutually agreed to release and discharge any and all claims that each may have
against the other party. The stock certificates were subsequently cancelled by
the Company's transfer agent. The Company recorded the stock acquisition as a
decrease to common stock with the corresponding offset to additional paid in
capital during the three months ended March 31, 2007.

NOTE 4 - CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

Financial instruments that subject the Company to credit risk are cash balances
maintained in excess of federal depository insurance limits and trade
receivables.

CASH AND CASH EQUIVALENTS

The Company maintains cash balances at several banks. Accounts at each
institution are insured by the Federal Deposit Insurance Corporation ("FDIC") up
to $100,000. As of March 31, 2007, the Company had consolidated balances of
approximately $480,000, which were not guaranteed by FDIC. The Company has not
experienced any losses in such accounts and believes the exposure is minimal.

MAJOR CUSTOMERS AND TRADE RECEIVABLES

A relatively small number of customers account for a significant percentage of
the Company's sales. The percentage of sales derived from significant customers
is as follows:

                                         THREE MONTHS ENDED
                                              MARCH 31,
                                         ------------------
                                         2007          2006
                                         ----          ----
                  Customer A              32%           37%
                  Customer B              21            --
                  Customer C              15            36

Trade receivables from these customers totaled $1,748,000 at March 31, 2007. As
of March 31, 2007 all the Company's trade receivables were unsecured.

NOTE 5 - CONCENTRATION OF SUPPLIER RISK

The Company purchases substantially all finished scanner imaging products from
one vendor that is also a wholly-owned subsidiary of the parent company of its
majority stockholder. See Note 3. If this vendor became unable to provide
materials in a timely manner and the Company was unable to find alternative
vendors, the Company's business, operating results and financial condition would
be materially adversely affected.


                                       8


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

NOTE 6 - EMPLOYEE EQUITY INCENTIVE PLANS

STOCK-BASED COMPENSATION

Sysview has several stock-based employee compensation plans, which are more
fully described in the Company's 2006 Annual Report on Form 10-KSB.

Effective January 1, 2006 Sysview adopted the fair value recognition provisions
of SFAS 123R, SHARE-BASED Payments, ("SFAS 123R") using the modified prospective
application method. Under this transition method, compensation cost recognized
for the three months ended March 31, 2007 and 2006, includes the applicable
amounts of: (a) compensation expense of all stock-based payments granted prior
to, but not yet vested as of January 1, 2006 (based on the grant-date fair value
estimated in accordance with the original provisions of SFAS 123 and the
Accounting Principles Board ("APB") 25, ACCOUNTING FOR STOCK ISSUED TO EMPLOYEES
("APB 25")), and (b) compensation expense for all stock-based payments granted
subsequent to January 1, 2006 (based on the grant-date fair value estimated in
accordance with the new provisions of SFAS 123R).

The following table sets forth the total stock-based compensation expense
included in the Condensed Consolidated Statements of Operations (IN THOUSANDS):

                                           THREE MONTHS ENDED
                                                MARCH 31,
                                           ------------------
                                           2007          2006
                                           ----          ----
              Selling and marketing        $ 73          $ 12
              General and administrative    508           271
              Research and development      233            12

At March 31, 2007, the Company had approximately $1,500,000 of total
unrecognized compensation cost related to unvested stock options. This cost is
expected to be recognized over a weighted-average period of approximately 22
months.

STOCK OPTIONS

The following table summarizes stock option activity and related information for
the three months ended March 31, 2007:


                                                              WEIGHTED-
                                                               AVERAGE
                                                              EXERCISE
                                                OPTIONS         PRICE
                                                ---------     ---------
          Outstanding at December 31, 2006      4,890,000     $    0.18
              Granted                           3,036,000          0.70
              Exercised                                --            --
              Cancelled                                --            --
                                                ---------     ---------
          Outstanding at March 31, 2007         7,926,000     $    0.38
                                                =========     =========


                                       9


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

The following table summarizes all options outstanding and exercisable by price
range as of March 31, 2007:

                           OPTIONS OUTSTANDING             OPTIONS EXERCISABLE
                  --------------------------------------  ----------------------
                                   WEIGHTED-
                                    AVERAGE    WEIGHTED-               WEIGHTED-
                                   REMAINING    AVERAGE                 AVERAGE
   RANGE OF          NUMBER       CONTRACTUAL   EXERCISE    NUMBER      EXERCISE
EXERCISE PRICES   OUTSTANDING    LIFE (YEARS)    PRICE    EXERCISABLE     PRICE
---------------   -----------    ------------    -----    -----------     -----

     $0.01         4,000,000         5.07        $0.01     2,666,666      $0.01
 $0.65 - $0.70     3,266,000         9.93        $0.70     1,069,500      $0.70
     $1.01           660,000         9.14        $1.01            --        --

NOTE 7 - BASIC AND DILUTED NET INCOME (LOSS) PER COMMON SHARE

Basic net income (loss) per common share is computed by dividing net income
(loss) by the weighted average number of shares of common stock outstanding
during the period. Diluted net income (loss) per common share is computed by
dividing net loss by the weighted average number of shares of common stock and
common stock equivalents outstanding during the period. Common stock equivalents
were not considered in calculating the Company's diluted net loss per common
share for the three months ended March 31, 2007 and 2006 as their effect would
be anti-dilutive. As a result, for all periods presented, the Company's basic
and diluted net loss per common share is the same.

NOTE 8 - EQUITY

COMMON STOCK ACTIVITY

As previously discussed in Note 3, the Company acquired 2,600,000 shares of the
Company's common stock during the three months ended March 31, 2007. The
Company's transfer agent subsequently cancelled the shares.

PREFERRED STOCK ACTIVITY

The Company had no preferred stock activity during the three months ended March
31, 2007.

SERIES A STOCK DIVIDENDS

The Company's Series A Stock accrues cumulative dividends at a rate of five
percent per annum, payable semiannually on July 1 and January 1. Dividends are
payable in cash, by accretion of the stated value or in shares of common stock.
Subject to certain terms and conditions, the decision whether to accrete
dividends to the stated value of the Series A Stock or to pay for dividends in
cash or in shares of common stock, is at the Company's discretion. To date, the
Company has not paid any dividends. During the three months ended March 31, 2007
and 2006, Series A Stock dividends were approximately $21,000 and $20,000,
respectively, and recorded as a non-operating expense on the Company's
consolidated statement of operations.

PREFERRED STOCK ACCOUNTING TREATMENT

Pursuant to SFAS 133, ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING
ACTIVITIES ("SFAS 133") and EITF Abstract No. 00-19, ACCOUNTING FOR DERIVATIVE
FINANCIAL INSTRUMENTS ("EITF 00-19"), the Company's Series A Stock and related
warrants and the Series B Stock and related warrants, are deemed derivative
instruments as a result of the embedded conversion feature. Accordingly, the
fair value of these derivative instruments has been recorded in the Company's
consolidated balance sheet as a liability with the corresponding amount as a
discount to the Series A Stock and Series B Stock, respectively. The discounts
are being accreted, on a straight-line basis, from the respective issuance date


                                       10


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

through the respective redemption date adjusted for conversions and are
disclosed as a non-operating expense on the Company's consolidated statement of
operations. Accretion of the preferred stock redemption value, for both Series A
and Series B, for the three months ended March 31, 2007 was approximately
$220,000. Accretion of the Series A preferred stock redemption value for the
three months ended March 31, 2006 was approximately $128,000. There was no
Series B accretion during the three months ended March 31, 2006 as the stock was
not issued until August 2006.

The increase in the fair value of the liability for derivative contracts, for
both Series A and Series B, totaled approximately $368,000 for the three months
ended March 31, 2007. The decrease in the fair value of the liability for the
Series A derivative contract totaled approximately $208,000 for the three months
ended March 31, 2006. The offsetting adjustment to the change in the fair value
of the liability for derivative contracts is disclosed with other income
(expense) in the consolidated statements of operations.

The Company computes fair value of these derivatives using the Black-Scholes
valuation model. The Black-Scholes model was developed for use in estimating the
fair value of traded options that have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions, including the expected stock price volatility. The
Company's derivative instruments have characteristics significantly different
from traded options, and the input assumptions used in the model can materially
affect the fair value estimate.

The assumptions used in the Black-Scholes valuation model to estimate fair value
of each derivative instrument and the resulting weighted average estimated value
of the Series A Stock derivative liability and the Series B Stock derivative
liability as of March 31, 2007 and 2006 are as follows:

                                                           MARCH 31,
                                                     --------------------
                                                       2007        2006
                                                     --------    --------
     Weighted average estimated values per share      $0.27       $0.36
     Expected life in years                             3.0         3.0
     Expected volatility                                 51%         42%
     Expected dividend yield                              0%          0%
     Risk free interest rate                            5.3%          5%

NOTE 9 - COMMITMENTS AND CONTINGENCIES

OPERATING LEASES

The Company is committed under various non-cancelable operating leases which
extend through November 2011. Future minimum rental commitments as of March 31,
2007 are as follows (IN THOUSANDS):

                                            FUTURE
                                            MINIMUM
                          YEAR ENDING        LEASE
                           MARCH 31,        PAYMENTS
                          -----------       --------
                              2008             $ 283
                              2009               195
                              2010                 1
                              2011                 1
                                            --------
                             Total             $ 480
                                            ========


                                       11


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

BANK LINE OF CREDIT

The Company has a line of credit agreement ("LOC Agreement") to borrow up to
$2,500,000, bearing interest at the rate of prime (8.25% at March 31, 2007) plus
0.5% and secured by all of the assets of the Company. Interest payments are due
monthly and all unpaid interest and principal is due in full on October 30,
2007. Upon certain events of default, the default variable interest rate
increases to prime plus 5.5%. The Company had $987,000 available for use at
March 31, 2007.

At March 31, 2007, Sysview was not in compliance with all of the LOC Agreement
debt covenants. Pursuant to a waiver letter from the lender dated May 14, 2007,
the lender agreed to forbear from exercising its rights and remedies with
respect to existing defaults under the LOC Agreement from the date of the
LOC Agreement through March 31, 2007. The Company is currently
renegotiating certain debt covenants defined by the LOC Agreement to more
accurately assess the Company's financial position.

EMPLOYMENT AGREEMENTS

The Company maintains employment agreements with its executive officers which
extend through 2008. The agreements provide for a base salary, annual bonus to
be determined by the Board of Directors, termination payments, stock options,
non-competition provisions, and other terms and conditions of employment. In
addition, the Company maintains employment agreements with other key employees
with similar terms and conditions. As of March 31, 2007 termination payments
totaling $490,000 remain in effect.

CONSULTING AGREEMENT

The Company entered into an Investor Relations Consulting Agreement dated
December 5, 2006, for a term of one year beginning January 1, 2007, payable
monthly as follows: (i) $5,000 for January, February and March; (ii) $7,500 for
April, May and June; (iii) $8,500 for July, August and September; and (iv)
$9,000 for October, November, and December. Additionally, the Company agreed to
pay the consultant 90,000 warrants with an exercise price of $0.65 per share,
expiring in three years, with immediate vesting on January 1, 2007, and
exercisable at the rate of 7,500 options the first day of each month during
calendar 2007. In April 2007, the Company entered a separate warrant agreement
that amended terms of the warrants awarded in the December 5, 2006 agreement.
Under the April 2007 agreement, the warrants shall vest 7,500 per month on the
first day of each month commencing on January 1, 2007 and are immediately
exercisable upon vesting. In the event the consulting agreement is terminated
prior to December 1, 2007, all unvested warrants shall be immediately cancelled.
The warrants will not be registered under federal or state securities laws. The
fair value of these warrants, as determined by the Black-Scholes valuation
model, totaled $18,000 and is amortized ratably over the vesting period. As
such, $4,000 was charged to general and administrative expense and credited to
additional paid-in capital during the three months ended March 31, 2007.

SERIES B PREFERRED STOCK REGISTRATION RIGHTS AGREEMENT

Pursuant to the terms of a registration rights agreement ("Agreement") between
the investors and the Company, the Company was obligated to file a registration
statement on Form SB-2 (which was filed on October 11, 2006) registering the
resale of shares of the Company's common stock issuable upon conversion of the
Series B Stock and exercise of the related warrants. The Company was required to
file the registration statement within 60 days following August 8, 2006 and to
have the registration statement declared effective by December 6, 2006, which is
120 days following August 8, 2006. If the registration statement was not timely
filed, or declared effective within the timeframe described, or if the
registration was suspended other than as permitted, in the Registration Rights
Agreement, the Company was obligated to pay each Investor a fee equal to one
percent of such investor's purchase price of the Series B Stock for each 30 day
period thereafter (pro rated for partial periods), that such registration
conditions are not satisfied, up to a maximum of 12 months. Because the SEC did
not declare the SB-2 effective until January 18, 2007, the Company accrued
approximately $7,000, included in general and administrative expense, for
damages during the three months ended March 31, 2007.


                                       12


                             SYSVIEW TECHNOLOGY, INC
       NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (UNAUDITED)

LITIGATION, CLAIMS AND ASSESSMENTS

The Company experiences routine litigation in the normal course of its business
and does not believe that any pending litigation will have a material adverse
effect on the Company's financial condition, results of operations or cash
flows.

NOTE 10 - SEGMENT AND GEOGRAPHIC INFORMATION

SEGMENT INFORMATION

Sysview currently operates in one segment, the design, development and delivery
of various imaging technology solutions, most notably scanners, as defined by
SFAS 131, DISCLOSURES ABOUT SEGMENTS OF AN ENTERPRISE AND RELATED INFORMATION
("SFAS 131").

GEOGRAPHIC INFORMATION

During the three months ended March 31, 2007 and 2006, Sysview recorded net
sales throughout the U.S., Asia and Europe as determined by the final
destination of the product. The following table summarizes total net sales
attributable to significant countries (IN THOUSANDS):

                                        THREE MONTHS ENDED
                                            MARCH 31,
                                    -------------------------
                                      2007             2006
                                    --------         --------
                   U.S.             $  4,001         $  2,221
                   Asia                    -              118
                   Europe and other      126               99
                                    --------         --------
                                    $  4,127         $  2,438
                                    ========         ========

Presented below is information regarding identifiable assets, classified by
operations located in the U.S. and Asia (IN THOUSANDS):

                                 MARCH 31,      DECEMBER 31,
                                   2007             2006
                                 ---------      -----------
                   U.S.          $   5,013      $     5,045
                   Asia                105               84
                                 ---------      -----------
                                 $   5,118      $     5,129
                                 =========      ===========

Assets located in Asia relate to tooling equipment required to manufacture
Sysview's product.


                                       13


ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

The following discussion should be read in conjunction with Sysview Technology,
Inc.'s ("Sysview" or "Company") unaudited condensed consolidated financial
statements and notes included herein. The results described below are not
necessarily indicative of the results to be expected in any future period.
Certain statements in this discussion and analysis, including statements
regarding our strategy, financial performance and revenue sources, are
forward-looking statements based on current expectations and entail various
risks and uncertainties that could cause actual results to differ materially
from those expressed in the forward-looking statements. Readers are referred to
Sysview's Annual Report on Form 10-KSB for the year ended December 31, 2006 as
filed with the Securities and Exchange Commission on April 3, 2007.

Management's discussion and analysis of financial condition and results of
operations ("MD&A") is provided as a supplement to the accompanying unaudited
condensed consolidated financial statements and notes to help provide an
understanding of our financial condition, changes in financial condition and
results of operations. The MD&A section is organized as follows:

o     OVERVIEW. This section provides a general description of the Company's
      business, as well as recent developments that we believe are important in
      understanding the results of operations and to anticipate future trends in
      those operations.

o     CRITICAL ACCOUNTING POLICIES. This section provides an analysis of the
      significant estimates and judgments that affect the reported amounts of
      assets, liabilities, revenues and expenses, and related disclosure of
      contingent assets and liabilities.

o     RESULTS OF OPERATIONS. This section provides an analysis of our results of
      operations for the three months ended March 31, 2007 compared to the three
      months ended March 31, 2006. A brief description of certain aspects,
      transactions and events is provided, including related party transactions
      that impact the comparability of the results being analyzed.

o     LIQUIDITY AND CAPITAL RESOURCES. This section provides an analysis of our
      financial condition and cash flows as of and for the three months ended
      March 31, 2007.

OVERVIEW

Our MD&A contains statements that are forward-looking. These statements are
based on current expectations and assumptions that are subject to risks and
uncertainties. Actual results could differ materially because of factors
discussed in this report, as well as factors not within our control. We
undertake no duty to update any forward-looking statement to conform the
statement to actual results or changes in our expectations.

We are in the business of designing, developing and delivering imaging
technology solutions. We currently have fourteen patents issued in the United
States and five patents issued in Taiwan. Additionally, we have five patents
currently pending with the United States Patent and Trademark Office, four
relate to our high definition ("HD") display technology and one relates to our
document/image-capture technology. We focus our research and development toward
new deliverable and marketable technologies. We sell our products to customers
throughout the world, including the United States, Canada, Europe, South
America, Australia and Asia. We intend to leverage our experience, expertise and
current technology in the document/image-capture market by expanding our
business to the HD display market, which is deemed to be a much larger market.

Our strategy is to expand our document/image-capture product line and technology
while leveraging our assets in other areas of the imaging industry. We are
actively shipping six groups of image-capture products. We have expanded our
document/image-capture product offerings, and will continue to expand in the
future, in response to the increased market demand for faster and easier-to-use
products as well as increased security to meet the growing need for information
protection, including identity and financial transaction protection. In addition
to expanding our image-capture product line, we actively pursue the acquisition
of technology and companies in the document/image-capture and display industry
to complement our business model, improve our competitive positioning and
further expand our product offerings.


                                       14


CRITICAL ACCOUNTING POLICIES

Our MD&A is based upon our condensed consolidated financial statements, which
have been prepared in accordance with accounting principles generally accepted
in the United States. The preparation of these financial statements requires us
to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets
and liabilities. On an on-going basis, we evaluate our estimates, including
those related to revenue recognition, trade receivables and allowance for
doubtful accounts, inventories, intangible and long-lived assets, and income
taxes. We base our estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources.
Actual results may differ from these estimates under different assumptions or
conditions.

An accounting policy is deemed to be critical if it requires an accounting
estimate to be made based on assumptions about matters that are highly uncertain
at the time the estimate is made, and if different estimates that reasonably
could have been used or changes in the accounting estimate that are reasonably
likely to occur could materially change the financial statements. We believe the
following critical accounting policies reflect our more significant estimates
and assumptions used in the preparation of our consolidated financial
statements:

REVENUE RECOGNITION

Revenues consist of sales of merchandise, including optical image capturing
devices, modules of optical image capturing devices, optical image chips and
other optoelectronic products. Revenue is recognized when the product is shipped
or delivered and the risks, rewards and title of ownership have transferred to
the customer. We recognize some shipping and handling fees as revenue, and the
related expenses as a component of cost of sales. All internal handling charges
are included with selling and marketing expense. Historically, sales returns
have not been significant. As such, we do not record a reduction to revenue for
estimated product returns in the same period that the related revenue is
recorded.

INVENTORY AND WARRANTY RESERVES

We establish inventory reserves for estimated obsolescence or unmarketable
inventory in an amount equal to the difference between the cost of inventory and
its estimated realizable value based upon assumptions about future demand and
market conditions. If actual demand and market conditions are less favorable
than those projected by management, additional inventory reserves could be
required. As of March 31, 2007, we had no inventory reserve. Currently, we
purchase the majority of our finished scanner imaging products from Syscan Lab
Limited ("SLL"), a wholly-owned subsidiary of Syscan Technology Holdings Limited
("STH"), the parent company of our majority stockholder. SLL warrants the
products it manufactures for us against defects in material and workmanship for
a period of 18 months after the completion of manufacture. After such 18 month
period, SLL provides product repair services for us at its customary hourly
repair rate plus the cost of any parts, components or items necessary to repair
the products. As a result of the product warranty provided by SLL, Sysview does
not record a product warranty reserve.

RELATED-PARTY TRANSACTIONS

We have significant related-party transactions and agreements, which we believe
have been accounted for at fair value. We utilized our best estimate of the
value of these transactions and agreements. Had alternative assumptions been
used, the values obtained may have been different.

RELATED-PARTY PURCHASES

The Company purchases the majority of its finished scanner imaging products from
SLL as discussed above. Our Chairman and CEO, Darwin Hu, was formerly the CEO of
STH. He resigned from STH effective December 2004.

Purchases from SLL totaled $2,178,000 and $1,409,000 during the three months
ended March 31, 2007 and 2006, respectively. All purchases from SLL were carried
out in the normal course of business. As a result of these purchases, the
Company was liable to SLL for $172,000 and $952,000 at March 31, 2007 and
December 31, 2006, respectively.


                                       15


COMMON STOCK ACQUIRED FROM RELATED PARTY

On March 21, 2007, we entered into an agreement with STH whereby we agreed to
forego any further collections efforts related to loans that we previously made
to STH, which were never repaid by STH, including legal action, in exchange for
the cancellation of 2,600,000 shares of our common stock beneficially owned by
STH. In addition, both parties mutually agreed to release and discharge any and
all claims that each may have against the other party. The stock certificates
were subsequently cancelled by the Company's transfer agent.

INTANGIBLE AND LONG-LIVED ASSETS

We evaluate our intangible assets and long-lived assets, which represent
goodwill, long-term investments, and fixed assets, for impairment annually or
more frequently if we believe indicators of impairment exist. Significant
management judgment is required during the evaluation, including the forecasts
of future operating results. The estimates we have used are consistent with the
plans and estimates that we use to manage our business. It is possible, however,
that the plans and estimates used may be incorrect. If our actual results, or
the plans and estimates used in future impairment analyses, are lower than the
original estimates used to assess the recoverability of these assets, we could
incur additional impairment charges. We had no such asset impairments during the
three months ended March 31, 2007.

INCOME TAXES

We utilize the liability method of accounting for income taxes. Deferred income
tax assets and liabilities are calculated as the difference between the
financial statements and tax basis of assets and liabilities that will result in
taxable or deductible amounts in the future, based on enacted tax laws and rates
applicable to the periods in which the differences are expected to affect
taxable income. We record a valuation allowance to reduce our deferred tax
assets to the amount that we believe is more likely than not to be realized. In
assessing the need for a valuation allowance, we consider all positive and
negative evidence, including scheduled reversals of deferred tax liabilities,
projected future taxable income, tax planning strategies, and recent financial
performance. The application of tax laws and regulations is subject to legal and
factual interpretation, judgment and uncertainty. Tax laws themselves are
subject to change as a result of changes in fiscal policy, changes in
legislation, evolution of regulations and court rulings. Therefore, the actual
income taxes may be materially different from our estimates. As a result of our
analysis, we concluded that a full valuation allowance against our net deferred
tax assets is appropriate at March 31, 2007.

CONTINGENCIES

From time to time, we are involved in disputes, litigation and other legal
proceedings. We record a charge equal to at least the minimum estimated
liability for a loss contingency when both of the following conditions are met:
(i) information available prior to issuance of the financial statements
indicates that it is probable that an asset had been impaired or a liability had
been incurred at the date of the financial statements and (ii) the range of loss
can be reasonably estimated. However, the actual liability in any such
litigation may be materially different from our estimates, which could result in
the need to record additional costs. Currently, we have no outstanding legal
proceedings or claims, which require a loss contingency.

ACCOUNTING FOR CERTAIN FINANCIAL INSTRUMENTS WITH CHARACTERISTICS OF BOTH
LIABILITIES AND EQUITY

We account for our Series A 5% cumulative convertible preferred stock ("Series A
Stock") and our Series B convertible preferred stock ("Series B Stock") pursuant
to SFAS 133, ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES ("SFAS
133") and the Emerging Issues Task Force ("EITF") Abstract 00-19, ACCOUNTING FOR
DERIVATIVE FINANCIAL INSTRUMENTS ("EITF 00-19"). Accordingly, the embedded
conversion feature associated with our Series A Stock and related warrants and
our Series B Stock and related warrants have been determined to be derivative
instruments. The fair value of these derivative instruments, as determined by
applying the Black-Scholes valuation model, is adjusted quarterly. The
Black-Scholes valuation model requires the input of highly subjective
assumptions, including the expected stock price volatility. Additionally,
although the Black-Scholes model meets the requirements of SFAS 133, the fair
values generated by the model may not be indicative of the actual fair values of
our Series A Stock and Series B Stock as our derivative instruments have
characteristics significantly different from traded options.


                                       16


STOCK-BASED COMPENSATION EXPENSE

Effective January 1, 2006 we adopted SFAS 123R, SHARE-BASED PAYMENTS ("SFAS
123R"). SFAS 123R, which requires all share-based payments, including grants of
employee stock options and warrants, to be recognized in our financial
statements based on their respective grant date fair values. Under this
standard, the fair value of each share-based payment award is estimated on the
date of grant using an option pricing model that meets certain requirements. We
currently use the Black-Scholes option pricing model to estimate the fair value
of our share-based payment awards. The Black-Scholes model meets the
requirements of SFAS 123R; however, the fair values generated by the model may
not be indicative of the actual fair values of our awards as it does not
consider certain factors important to our awards, such as continued employment,
periodic vesting requirements and limited transferability.

The determination of the fair value of share-based payment awards utilizing the
Black-Scholes model is affected by our stock price and a number of assumptions,
including expected volatility, expected life, risk-free interest rate and
expected dividends. We use the historical volatility for our common stock as the
expected volatility assumption required in the Black-Scholes model, which could
be significantly different than actual volatility. The expected life of the
awards is based on historical and other economic data trended into the future.
The risk-free interest rate assumption is based on observed interest rates
appropriate for the terms of our awards. The dividend yield assumption is based
on our history and expectation of dividend payouts. Forfeitures are estimated at
the time of grant and revised, if necessary, in subsequent periods if actual
forfeitures differ from those estimates.

Stock-based compensation expense recognized in our financial statements
beginning January 1, 2006 and thereafter is based on awards that are ultimately
expected to vest. We evaluate the assumptions used to value our awards on a
quarterly basis. If factors change and we employ different assumptions,
stock-based compensation expense may differ significantly from what we have
recorded in the past. If there are any modifications or cancellations of the
underlying unvested securities, we may be required to accelerate, increase or
cancel any remaining unearned stock-based compensation expense. Future
stock-based compensation expense and unearned stock-based compensation will
increase to the extent that we grant additional equity awards to employees.


                                       17


RESULTS OF OPERATIONS

The following table summarizes certain aspects of our results of operations for
the three months ended March 31, 2007 compared to the three months ended March
31, 2006 (IN THOUSANDS):

                                          THREE MONTHS
                                         ENDED MARCH 31,
                                        ------------------
                                          2007       2006    $ CHANGE   % CHANGE
                                        -------    -------   --------   --------

Net sales                               $ 4,127    $ 2,438    $1,689        69%

Cost of sales                             2,484      1,616       868        54

   As a percentage of sales                  60%        66%

  Selling and marketing expense             400        293       107        37
  General and administrative expense        915        608       307        50
  Research and development expense          777        396       381        96

Total other income (expense)               (359)       203        NM        NM
Dividend on 5% convertible preferred
  stock and accretion of preferred
  stock redemption value                   (241)      (148)       NM        NM

Net loss available to common
  Stockholders                           (1,049)      (420)     (629)     (150)

NM = Not Meaningful

NET SALES

The significant increase in net sales during the three months ended March 31,
2007 as compared to the three months ended March 31, 2006 was attributable to
the following:

      o     The overall growth of the document/image capture market resulting
            from an increased market demand for products that manage
            information, including how information is retrieved, stored, shared
            and disseminated;

      o     The increased end user market penetration, including distribution
            channel expansion, by both us and our largest customers;

      o     The increased market acceptance of our more recently introduced
            products;

      o     Our sales during the three months ended March 31, 2007 experienced
            substantially less of a cyclical downturn as compared to the three
            months ended March 31, 2006. We attribute this more consistent
            market delivery of our product to (i) the growth of our smaller
            customers and less dependence on our larger customers, (ii) our
            management of customer demand and product delivery and (iii) our
            movement toward a just-in-time inventory management product delivery
            system;

      o     Our increased usage of Value Added Reseller ("VAR") channel
            distributions; and

      o     The growth in the small office home office ("SOHO") markets, and the
            result of our efforts to appeal to customers in the SOHO market.

Sales to our three largest customers represented 68% and 73% for the three
months ended March 31, 2007 and 2006, respectively. We expect that our largest
customers will continue to account for a substantial portion of our net sales in
the remainder of fiscal 2007 and for the foreseeable future. The identities of
our largest customer and their respective contributions to our net sales have
varied and will likely continue to vary from period to period.


                                       18


Although we expect net sales to increase as we continue to expand our business
and offer additional products in the document/image-capture market and expand to
the HD display market, there can be no assurance that our net sales will
increase.

COST OF SALES, INCLUDING GROSS PROFIT

Cost of sales includes all direct costs related to the transfer of scanners,
imaging modules and services related to the delivery of those items manufactured
in China, and to a lesser extent engineering services and software royalties.
Cost of sales increased in absolute dollars as a result of the increased net
sales during the three months ended March 31, 2007 as compared to the three
months ended March 31, 2006. Cost of sales as a percentage of net sales
decreased as a result of a higher proportion of overall net sales being
generated from our most recently introduced and more feature rich products,
including our duplex scanners (scanners that have the ability to scan both sides
of a document at once). Our duplex scanners, which bear a higher gross margin
than our simplex scanners (scanners that scan only one side of a document) have
recently experienced broader market acceptance.

We expect our cost of sales as a percentage of net sales to fluctuate somewhat
as our product mix fluctuates. Our average selling price and related material
cost used to manufacture our product has been stable and we expect this trend to
continue for the foreseeable future.

SELLING AND MARKETING EXPENSE

Selling and marketing expenses consist primarily of salaries and related costs
of employees, including stock-based compensation costs, engaged in our sales,
marketing and customer account management functions and to a lesser extent
market development and promotional funds for our retail distribution channels,
tradeshows, website support, warehousing, logistics and certain sales
representative fees. The increase during the three months ended March 31, 2007
as compared to the three months ended March 31, 2006 is primarily attributable
to stock-based compensation cost (a non-cash charge) as a result of granting
stock options to key employees during the three months ended March 31, 2007 and
accounting for such option grants under SFAS 123R. See "Note 6: Employee Equity
Incentive Plans" in Part I, Item 1 of this Form 10-QSB. Stock-based compensation
cost was $73,000 for the three months ended March 31, 2007 as compared to
$12,000 for the three months ended March 31, 2006. To a lesser extent, the
increase during the three months ended March 31, 2007 as compared to the three
months ended March 31, 2006 was attributable to our increased staff and related
marketing activities to support our expanding product offerings and the addition
of direct sales personnel in Europe and Asia. Although we expect sales and
marketing expenses to fluctuate as a result of the timing of advertising and
promotions of our various new products and stock option grants, overall we
expect selling and marketing expenses to increase as we continue to expand our
marketing efforts and the number of products we offer.

GENERAL AND ADMINISTRATIVE EXPENSE

General and administrative expense consists primarily of costs associated with
our executive, financial, human resources and information services functions,
including stock-based compensation costs, facilities-related expenses and
outside professional services such as legal and accounting. The increase during
the three months ended March 31, 2007 as compared to the three months ended
March 31, 2006 is primarily attributable to stock-based compensation cost (a
non-cash charge) as a result of granting stock options to key employees and
directors during the three months ended March 31, 2007 and accounting for such
option grants under SFAS 123R. See "Note 6: Employee Equity Incentive Plans" in
Part I, Item 1 of this Form 10-QSB. Stock-based compensation cost was $508,000
for the three months ended March 31, 2007 as compared to $271,000 for the three
months ended March 31, 2006. Additionally, our general and administrative
expenses increased during the three months ended March 31, 2007 as compared to
the three months ended March 31, 2006 as a result of hiring an outside investor
relations firm to manage and enhance our investor relations function. The
remaining increase is a result of increased personnel costs to support our
expanding business and related infrastructure and the increased expenses
associated with maintaining our public company status. We anticipate that
general and administrative expenses will continue to increase over the long term
as our business continues to grow and the costs associated with being a public
company continue to increase as a result of our required reporting requirements,
including but not limited to expenses incurred to comply with the Sarbanes-Oxley
Act of 2002.


                                       19


RESEARCH AND DEVELOPMENT EXPENSE

Research and development expense consists primarily of salaries and related
costs, including stock-based compensation costs, of employees engaged in product
research, design and development activities, compliance testing, documentation,
prototypes and expenses associated with transitioning the product to production.
The increase during the three months ended March 31, 2007 as compared to the
three months ended March 31, 2006 is primarily attributable to stock-based
compensation cost (a non-cash charge) as a result of granting stock options to
key employees during the three months ended March 31, 2007 and accounting for
such option grants under SFAS 123R. See "Note 6: Employee Equity Incentive
Plans" in Part I, Item 1 of this Form 10-QSB. Stock-based compensation cost was
$233,000 for the three months ended March 31, 2007 as compared to $12,000 for
the three months ended March 31, 2006. The remaining increase is a result of
increased number of employees engaged in research and development activities,
resulting from both direct hiring and acquisitions, and the increased amount of
expensed equipment required to support our future product development. The
majority of our research and development expenses during both the three months
ended March 31, 2007 and 2006 were directly attributable to our future products
which include HD display We anticipate that research and development expense
will continue to increase over the long term as a result of the growth and
diversification of the products we offer, new product opportunities and our
continued efforts to invest in the future and strengthen our intellectual
property position within our highly competitive market.

TOTAL OTHER INCOME (EXPENSE)

Other income (expense) for the three months ended March 31, 2007 was mainly
attributable to the $368,000 increase in the fair value of the liability for
derivative contracts (associated with our Series A Stock and related warrants
and Series B Stock and related warrants). Other income (expense) for the three
months ended March 31, 2006 was mainly attributable to the $208,000 decrease in
the fair value of the liability for derivative contracts (associated with our
Series A Stock and related warrants). Pursuant to SFAS 133, ACCOUNTING FOR
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES, ("SFAS 133") and EITF Abstract
00-19, ACCOUNTING FOR DERIVATIVE FINANCIAL INSTRUMENTS ("EITF 00-19"), the
increase in the fair value of the liability for derivative contracts is included
as other expense in our consolidated statements of operations and the decrease
in the fair value of the liability for derivative contracts is included as other
income in our consolidated statements of operations.

DIVIDEND ON SERIES A STOCK AND ACCRETION OF PREFERRED STOCK REDEMPTION VALUE

During the three months ended March 31, 2007 and 2006 the total accretion on our
preferred stock was $220,000 and $128,000, respectively. The increase is
attributable to our Series B Stock, which was outstanding during the three
months ended March 31, 2007 but was not outstanding during the three months
ended March 31, 2006. During the three months ended March 31, 2007 and 2006,
Series A Stock dividends were approximately $21,000 and $20,000, respectively,
and recorded as a non-operating expense on the Company's statement of
operations. We do not pay dividends on our Series B Stock.

LIQUIDITY AND CAPITAL RESOURCES

At March 31, 2007, our principal sources of liquidity included cash and cash
equivalents of $864,000 and unused borrowing capacity of $987,000 under our bank
line of credit. We had no significant cash outlays, except as part of our normal
operations, during the three months ended March 31, 2007.

Operating activities: During the three months ended March 31, 2007, our
operating activities used $937, 000 of cash. This was primarily a result of our
$1,049,000 net loss, $1,415,000 of net non-cash expenses and $1,303,000 net cash
used by changes in operating assets and liabilities. During the three months
ended March 31, 2006, our operating activities used $382,000 of cash. This was
primarily a result of our $420,000 net loss, $226,000 of net non-cash expenses
and $188,000 net cash used by changes in operating assets and liabilities.
Non-cash items included in net loss for both the three months ended March 31,
2007 and 2006 include depreciation expense, stock-based compensation cost of
options, fair value of warrants issued for services rendered, change in fair
value of derivative instruments and the accretion of our Series A and Series B
preferred stock redemption value.


                                       20


Our trade receivables increased during both the three months ended March 31,
2007 and 2006 as a result of the significant increase in sales of our product.
Our inventory decreased during both the three months ended March 31, 2007 and
March 31, 2006 due to the timing of purchasing our product and inventory
management.

The most significant use of cash during the three months ended March 31, 2007
was attributable to paying our contract manufacturer according to the specified
payments terms. We expect future cash provided (used) by operating activities to
fluctuate, primarily as a result of fluctuations in our operating results,
timing of product shipments, trade receivables collections, inventory management
and timing of vendor payments.

Investing activities: Our investing activities for both the three months ended
March 31, 2007 and 2006 were minimal and consisted of purchasing computer
equipment in the normal course of business.

Financing activities: During the three months ended March 31, 2007, our
financing activities consisted solely of a $500,000 draw against our bank line
of credit to meet short term obligations, including payment on the purchase of
our product. We anticipate the additional $500,000 draw to be temporary to meet
short term working capital needs. We had no financing activities during the
three months ended March 31, 2006.

CASH AND WORKING CAPITAL REQUIREMENTS

As previously discussed, we plan to continue increasing our presence in the
document/image-capture market and expand our operations into the HD display
market, which may require additional capital. Additionally, we may seek to
expand our operations through acquisitions of companies in either the
document/image-capture market or the HD display market that we believe could
complement our business model, improve our competitive positioning and expand
our product offerings.

Considering current cash reserves and other sources of liquidity, including our
bank line of credit, management believes that the Company will have sufficient
sources of financing to continue its normal operations through at least the next
twelve months. However, our business expansion plans may require additional
capital through either the incurrence of debt or the issuance of equity
securities, or a combination thereof, depending on the prevailing market and
other conditions. There is no assurance that such additional funds will be
available for us to finance our expansion plans. Furthermore, there is no
assurance the net proceeds from any successful financing arrangement will be
sufficient to cover cash requirements as we expand our business operations.

CONTRACTUAL OBLIGATIONS

The following table summarizes our contractual obligations at March 31, 2007,
and the effect such obligations are expected to have on our liquidity and cash
flows in future periods (IN THOUSANDS):



                                              LESS THAN   ONE - THREE   THREE - FIVE
                                     TOTAL     ONE YEAR      YEARS          YEARS
                                    -------   ---------   -----------   ------------
                                                                
Line of credit (1)                  $ 1,513    $ 1,513       $   --         $  --

Operating lease obligations             480        283          196             1
Consulting agreement                     75         75           --            --
                                    -------   ---------   -----------   ------------
Total contractual cash obligations  $ 2,068    $ 1,871       $  196         $   1
                                    =======   =========   ===========   ============


(1) The Company has a line of credit agreement ("LOC Agreement") to borrow up to
$2,500,000, bearing interest at the rate of prime (8.25% at March 31, 2007) plus
0.5% and secured by all of the assets of the Company. Interest payments are due
monthly and all unpaid interest and principal is due in full on October 30,
2007. Upon certain events of default, the default variable interest rate
increases to prime plus 5.5%. The Company had $987,000 available for use at
March 31, 2007.

At March 31, 2007, Sysview was not in compliance with all of the LOC Agreement
debt covenants. Pursuant to a waiver letter from the lender dated May 14, 2007,
the lender agreed to forbear from exercising its rights and remedies with
respect to existing defaults under the LOC Agreement from the date of the
LOC Agreement through March 31, 2007. The Company is currently
renegotiating certain debt covenants defined by the LOC Agreement to more
accurately assess the Company's financial position.


                                       21


OFF-BALANCE SHEET ARRANGEMENTS

At March 31, 2007, we did not have any relationship with unconsolidated entities
or financial partnerships, which other companies have established for the
purpose of facilitating off-balance sheet arrangements or other contractually
narrow or limited purposes as defined in Item 303(c)(2) of SEC Regulation S-B.
Therefore, we are not materially exposed to any financing, liquidity, market or
credit risk that could arise if we had engaged in such relationships.

TRENDS

As of March 31, 2007, to the best of our knowledge, no known trends or demands,
commitments, events or uncertainties, except as described in "NOTE 9:
COMMITMENTS AND CONTINGENCIES" existed, which are likely to have a material
effect on our liquidity.


                                       22


ITEM 3 - CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including
our principal executive officer and principal financial officer, we conducted an
evaluation of the effectiveness of the design and operation of our disclosure
controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the
Securities Exchange Act of 1934 as of the end of the period covered by this
report (the "Evaluation Date"). Based upon the evaluation, our principal
executive officer and principal financial officer concluded as of the Evaluation
Date that our disclosure controls and procedures were effective. Disclosure
controls are controls and procedures designed to reasonably ensure that
information required to be disclosed in our reports filed under the Exchange
Act, such as this report, is recorded, processed, summarized and reported within
the time periods specified in the SEC's rules and forms. Disclosure controls
include controls and procedures designed to reasonably ensure that such
information is accumulated and communicated to our management, including our
chief executive officer and chief financial officer, as appropriate to allow
timely decisions regarding required disclosure.

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

There were no changes in our internal controls over financial reporting that
occurred during the quarterly period covered by this report that have materially
affected, or are reasonably likely to materially affect, our internal control
over financial reporting.


                                       23


PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are subject to various legal proceedings from time to time in the ordinary
course of business, none of which is required to be disclosed under this Item 1.

ITEM 6 - EXHIBITS

 EXHIBIT
  NUMBER    DESCRIPTION OF EXHIBIT              METHOD OF FILING
--------    --------------------------------    -------------------------------
     2.1    Share Exchange Agreement            Incorporated by reference to
                                                Exhibit 99.1 to Form 8-K dated
                                                April 19, 2004

     3.1    Certificate of Incorporation,       Incorporated by reference to
            dated February 15, 2002             Exhibit 3.1 on Form 10-KSB
                                                dated March 31, 2005

     3.2    Certificate of Amendment to the     Incorporated by reference to
            Company's Certificate of            Exhibit 3.2 on Form 10-KSB
            Incorporation dated March 19,       dated March 31, 2005
            2004

     3.3    Certificate of Designation of       Incorporated by reference to
            Preferences, Rights and             Exhibit 10.4 on Form 8-K dated
            Limitations of Series A Stock       March 21, 2005
            as filed with the Secretary of
            State of the State of Delaware
            on March 15, 2005

     3.4    Amended and Restated Bylaws         Incorporated by reference to
                                                Exhibit 3.4 on Form 10-KSB
                                                dated March 31, 2005

     3.5    Certificate of Amendment to the     Incorporated by reference to
            Company's Certificate of            Exhibit 3.5 on Form 10-QSB
            Incorporation dated June 23,        dated August 21, 2006
            2006

     3.6    Certificate of Designation of       Incorporated by reference to
            Preferences, Rights and             Exhibit 10.4 on Form 8-K dated
            Limitations of Series B Stock       August 14, 2006
            as filed with the Secretary of
            State of the State of Delaware
            on June 10, 2006

    10.1    Form of Series A Convertible        Incorporated by reference to
            Preferred Stock and Common          Exhibit 10.1 on Form 8-K dated
            Stock Warrant Purchase              March 21, 2005
            Agreement entered into by and
            between the Company and the
            purchasers

    10.2    Form of Common Stock Purchase       Incorporated by reference to
            Warrant                             Exhibit 10.2 on Form 8-K dated
                                                March 21, 2005

    10.3    Form of Registration Rights         Incorporated by reference to
            Agreement                           Exhibit 10.3 on Form 8-K dated
                                                March 21, 2005

    10.4    2002 Amended and Restated Stock     Incorporated by reference to
            Option Plan                         Exhibit 10.4 on Form 10-KSB
                                                dated March 31, 2005

    10.5    Employment Agreement entered        Incorporated by reference to
            between the Company and Darwin      Exhibit 10.5 on Form 8-K dated
            Hu on April 26, 2005                May 2, 2005

    10.6    Employment Agreement entered        Incorporated by reference to
            between the Company and William     Exhibit 10.6 on Form 8-K dated
            Hawkins on April 26, 2005           May 2, 2005

    10.7    Employment Agreement entered        Incorporated by reference to
            between the Company and David       Exhibit 10.7 on Form 8-K dated
            P. Clark on April 26, 2005          May 2, 2005

    10.8    2006 Stock Option                   Incorporated by reference to
            Plan                                Exhibit 10.8 on Form 10-QSB
                                                dated August 21, 2006


                                       24


 EXHIBIT
  NUMBER    DESCRIPTION OF EXHIBIT              METHOD OF FILING
--------    --------------------------------    -------------------------------
    10.9    Form of Series B Convertible        Incorporated by reference to
            Preferred Stock and Common          Exhibit 10.1 on Form 8-K dated
            Stock Warrant Purchase              August 14, 2006
            Agreement entered into by and
            between the Company and the
            purchasers

   10.10    Form of Common Stock Purchase       Incorporated by reference to
            Warrant                             Exhibit 10.2 on Form 8-K dated
                                                August 14, 2006

   10.11    Form of Registration Rights         Incorporated by reference to
            Agreement                           Exhibit 10.3 on Form 8-K dated
                                                August 14, 2006

   10.12    Lease Agreement by and between      Incorporated by reference to
            the Company and Airport II          Exhibit 10.12 on Form 10-KSB
            Property Management, LLC dated      dated April 3, 2007
            August 9, 2006

    31.1    Certification Pursuant to           Filed herewith
            Section 302 of the
            Sarbanes-Oxley Act - Darwin Hu

    31.2    Certification Pursuant to           Filed herewith
            Section 302 of the
            Sarbanes-Oxley Act - William
            Hawkins

    32.1    Certifications Pursuant to          Filed herewith
            Section 906 of the
            Sarbanes-Oxley Act - Darwin Hu

    32.2    Certifications Pursuant to          Filed herewith
            Section 906 of the
            Sarbanes-Oxley Act - William
            Hawkins


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Sysview
Technology, Inc. has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                 SYSVIEW TECHNOLOGY, INC.


                                 Date: May 15, 2007

                                 /S/ DARWIN HU
                                 -------------------
                                 Darwin Hu, Chairman and Chief Executive Officer


                                 Date: May 15, 2007

                                 /S/ WILLIAM HAWKINS
                                 -------------------
                                 William Hawkins, Acting Chief Financial Officer
                                 Chief Operating Officer and Secretary